A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed to establish a conclusive benefit.

A latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...

Researchers looked at the nine people who had vision problems while using the drugs and is one of several that have ...

The beverage giant is ready to manage, mitigate and adjust to the “dynamic macro environment,” including potential tariffs ...

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — experienced vision issues, including three potentially blinding eye conditions.

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.

The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

WVU Medicine is playing a lead role in a national clinical study of a minimally invasive surgical procedure for people who've ...